Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Lini Imaji Kreasi Ekosistem Tbk. (FUTR) vs Tempo Scan Pacific Tbk. (TSPC)

Lini Imaji Kreasi Ekosistem Tbk.Trading
Tempo Scan Pacific Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Lini Imaji Kreasi Ekosistem Tbk. dan Tempo Scan Pacific Tbk.: Lini Imaji Kreasi Ekosistem Tbk. diperdagangkan di Rp226 (kapitalisasi pasar 1,49 T, volume 24 jam 28,32 jt), sedangkan Tempo Scan Pacific Tbk. diperdagangkan di Rp2.520 (kapitalisasi pasar 11,18 T, volume 24 jam 613 rb). Perbedaan utamanya: Tempo Scan Pacific Tbk. jauh lebih besar — sekitar 7,5× kapitalisasi pasar Lini Imaji Kreasi Ekosistem Tbk., dan Lini Imaji Kreasi Ekosistem Tbk. lebih aktif diperdagangkan (28,32 jt vs 613 rb). Mana yang lebih baik tergantung tujuan investasimu.

FUTRTSPC
Kapitalisasi Pasar
1,49 T11,18 T
Volume
28,32 jt613 rb
Lot
283,22 rb6,13 rb
Perputaran
6,41 M1,54 M
Harga Rata-rata
226,292.511,52
Nilai Transaksi
6,41 M1,54 M
Harga Ekuilibrium Indikatif
2262.520
Volume Ekuilibrium Indikatif
4,51 rb17

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

FUTR
Lihat detail
TSPC
Lihat detail

Tentang Lini Imaji Kreasi Ekosistem Tbk.

PT Lini Imaji Kreasi Ekosistem Tbk (the “Company”) was established under the name of PT LinikiniAspirasi Kreasi based on Notarial Deed No. 74 of Janty Lega, S.H., M.Kn., dated July 29, 2021. The Company started its commercial operations in 2021. The immediate and ultimate parent entities of the Company are PT Digital Futurama Global and PT Investasi Gemilang Maju, respectively.

Selengkapnya di halaman FUTR

Tentang Tempo Scan Pacific Tbk.

PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.

Selengkapnya di halaman TSPC